K. Maeno

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.

Tokio Yamaguchi, Akiko Koakutsu, Yasuharu Kimura, 2004, European journal of pharmacology.

Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.

S. Tsukamoto, K. Sugasawa, S. Sakamoto, 2008, Bioorganic & medicinal chemistry.

Chronic treatment with the (iso-)glutaminyl cyclase inhibitor PQ529 is a novel and effective approach for glomerulonephritis in chronic kidney disease

N. Kanemitsu, Hiroyuki Ito, Fumiko Kiyonaga, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.

S. Tsukamoto, S. Sakamoto, H. Kubota, 2008, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of 3-biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as novel glycine transporter 1 inhibitors.

A. Kohara, S. Tsukamoto, S. Sakamoto, 2011, Journal of medicinal chemistry.

Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors.

Shuichi Sakamoto, Junji Miyata, Takashi Sugane, 2013, Journal of medicinal chemistry.

Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.

S. Usuda, T. Mase, M. Matsumoto, 1996, Journal of medicinal chemistry.